Literature DB >> 9124864

Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.

S Unal1, M Hayran, S Tuncer, D Gür, O Uzun, M Akova, H E Akalin.   

Abstract

In this prospective study of enteric fever, 22 patients received 400 mg of pefloxacin twice daily for 5 days (group A) and 24 received 400 mg of pefloxacin twice daily for 7 days (group B). Causative microorganisms were Salmonella typhi (8 in group A, 11 in group B) and Salmonella paratyphi B (14 in group A, 13 in group B). The clinical cure and bacterial eradication rates were 96% (21 of 22) in group A and 100% in group B. In conclusion, 5-day oral administration of pefloxacin was as effective as 7-day treatment of enteric fever caused by Salmonella spp.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9124864      PMCID： PMC163645     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  The efficacy and safety of pefloxacin in the treatment of typhoid fever in Algeria.

Authors:  A Ait-Khaled; L Zidane; A Amrane; R Aklil
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

2.  Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children.

Authors:  H Vinh; J Wain; T N Vo; N N Cao; T C Mai; D Bethell; T T Nguyen; S D Tu; M D Nguyen; N J White
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

3.  Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of Salmonella enteric fever.

Authors:  B M Limson; R T Littaua
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

4.  Ofloxacin in treatment of typhoid fever: a preliminary study.

Authors:  W L Lo
Journal:  J Antimicrob Chemother       Date:  1988-05       Impact factor: 5.790

5.  [Evaluation of the use of ofloxacin in the treatment of various infections].

Authors:  D Peyramond; S Tigaud; F Lucht; J M Vedrinne; F Salord; J L Bertrand
Journal:  Pathol Biol (Paris)       Date:  1986-05

6.  Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.

Authors:  M Hajji; N el Mdaghri; M Benbachir; K M el Filali; H Himmich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

Review 7.  Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones.

Authors:  J P Bryan; H Rocha; W M Scheld
Journal:  Rev Infect Dis       Date:  1986 Mar-Apr

Review 8.  General considerations in the management of typhoid fever and dysentery.

Authors:  R H Gilman
Journal:  Scand J Gastroenterol Suppl       Date:  1989

9.  Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.

Authors:  M D Smith; N M Duong; N T Hoa; J Wain; H D Ha; T S Diep; N P Day; T T Hien; N J White
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191
  9 in total
  2 in total

Review 1.  Quinolones in the treatment of typhoid fever.

Authors:  H E Akalin
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 2.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.